Vitamin A Dosing for Measles in Children by Age
All children with measles must receive vitamin A supplementation on day 1: children ≥12 months receive 200,000 IU orally, and children <12 months receive 100,000 IU orally. 1
Standard Single-Dose Regimen (Day 1 Only)
Children ≥12 months (including adolescents and adults)
- Dose: 200,000 IU oral vitamin A 1
- Timing: Day 1 of diagnosis 1
- Frequency: Single dose (unless complications develop) 1
- Prerequisite: Patient has not received vitamin A in the preceding month 1
Infants <12 months (including those <6 months)
- Dose: 100,000 IU oral vitamin A 1, 2
- Timing: Day 1 of diagnosis 1
- Frequency: Single dose (unless complications develop) 1
- Prerequisite: Patient has not received vitamin A in the preceding month 1
Enhanced Two-Dose Regimen for Complicated Measles
Administer an identical second dose on day 2 when any complication is present—this protocol reduces overall mortality by 64% (RR 0.36) and pneumonia-specific mortality by 67% (RR 0.33). 1
Indications for Second Dose (Day 2)
The following complications mandate a second identical dose: 1
- Pneumonia or acute lower respiratory infection
- Otitis media
- Croup or laryngotracheobronchitis
- Diarrhea with moderate or severe dehydration
- Neurological problems (altered consciousness, seizures, encephalitis)
Dosing for Complicated Cases
Children ≥12 months:
Infants <12 months:
The mortality reduction is most pronounced in children <2 years (82% reduction, RR 0.18). 1
Extended Three-Dose Protocol for Vitamin A Deficiency with Eye Signs
When eye manifestations of vitamin A deficiency are present, give a third dose 1–4 weeks after the initial two doses. 1, 3
Eye Signs Requiring Third Dose
Any of the following indicate vitamin A deficiency: 3
- Xerosis (dryness of conjunctiva or cornea)
- Bitot's spots (foamy conjunctival patches)
- Keratomalacia (corneal softening)
- Corneal ulceration
Three-Dose Schedule
Children ≥12 months:
Infants <12 months:
Critical Clinical Context and Evidence Strength
The two-dose regimen is supported by the highest-quality evidence showing substantial mortality benefit. A Cochrane systematic review found that two doses of 200,000 IU reduced mortality by 64% overall, with water-based formulations showing 81% reduction versus 48% for oil-based preparations. 4 Single-dose regimens showed no significant mortality reduction (RR 0.77,95% CI 0.34–1.78). 4
The benefit is greatest in children under 2 years of age, where two-dose vitamin A reduces mortality by 82%. 1, 4
Common Pitfalls to Avoid
- Do not wait for laboratory confirmation before administering vitamin A—treatment should begin based on clinical diagnosis. 2
- Do not withhold vitamin A due to toxicity concerns—the standard protocol is safe, as acute toxicity requires >300,000 IU in adults or >60,000 IU in children. 3
- Do not use a single dose for complicated measles—the evidence supports two doses for mortality reduction. 1, 4
- Do not forget to assess for eye signs—these mandate a third dose at 1–4 weeks. 1, 3
Long-Term Follow-Up in At-Risk Populations
In communities with high vitamin A deficiency prevalence, children should receive additional oral vitamin A supplementation every 3 months after completing acute measles treatment. 1, 2